stemsavelogo

Select Country

877-783-6728 (877-StemSave)

StemSave Blog

The Antidote to the Clinical Trial Bottleneck

Posted by hunter@stemsave.com on Feb 10, 2018 3:21:00 PM

Read More

Topics: Phase I/II clinical trials, clinical trials, FDA approval

Combatting Alzheimer’s Disease with Stem Cells

Posted by pamela@stemsave.com on Jun 28, 2017 1:45:00 PM

Biostar Stem Cell Research institute has developed a protocol  for the use of autologous [the patient’s own] stem cells to combat Alzheimer’s Disease with the FDA has approving Phase I and II clinicals trials for the new treatment. The process involves recovering, isolating and culturing the patient’s own stem cells. Culturing the cells results in the production of a clinically significant number of cells, enabling an extended treatment period and protocol. These cells are injected intravenously across ten treatments, using approximately 200 million cells each time. By utilizing the patient’s own stem cells to address neural degradation, the researchers anticipate the treatment may go a long way to both slow the degenerative progression of the disease, while also addressing the root cause of Alzheimer’s Disease.

Read More

Topics: regenrative medicine, Alzheimer's disease, Phase I/II clinical trials, FDA approval

Stem Cell Treatment for Dry Age-Related Macular Degeneration Entering Clinical Trial Phase

Posted by Kelsey StemSave on Nov 9, 2012 5:00:16 AM

 

 

 

 

 

A Phase I/II clinical trial to treat dry age-related macular degeneration (Dry-AMD) is being conducted by StemCells, Inc. Dry-AMD is the most common type of macular degeneration and affects 90% of patients with the condition. It is a chronic eye disease that causes vision loss in the center of the field of vision and is the major cause of blindness and visual impairment in adults older than 50.

Read More

Topics: Phase III, neural stem cells, clinical trials, dry age-related macular degeneration, Stemcells, Phase I/II clinical trials, clinical trial, Dry AMD, StemCells Inc., AMD, stemsaveblog

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

    Recent Posts

    Posts by Topic

    see all